Abstract
Serum ferritin, a marker of iron stores and inflammation, has been linked to metabolic syndrome (MetS), a cluster of conditions including abdominal obesity, dyslipidemia, hypertension, and insulin resistance. Elevated serum ferritin levels have been associated with the pro-inflammatory state of MetS, suggesting its potential role as a biomarker for metabolic risk. This study evaluates serum ferritin levels in patients with MetS and investigates its correlation with individual components of MetS. Findings highlight the relevance of ferritin in understanding MetS pathogenesis and its utility in risk assessment.
Keywords: Serum ferritin, metabolic syndrome, inflammation, insulin resistance, biomarkers